Company Profile

Established in 2005, Med-Zenith (Beijing Med-Zenith Medical Scientific Co., Ltd.) is a company that specializes in the research and development, production, and sales of medical devices and biomedical engineering materials.  Med-Zenith's products cover areas such as structural heart disease (both congenital heart disease and valvular heart disease), arrhythmia (atrial fibrillation), and heart failure.  The company is committed to providing professional solutions for the treatment of cardiovascular diseases, establishing a wide range of cooperative and academic exchanges with international and domestic experts, and establishing a cooperation platform for clinic, research and product development.  This vision and corresponding objectives should allow us to become a leading technology and healthcare service provider in the field of cardiovascular disease treatment in China.

Key technical attributes of Med-Zenith:

·       48 patents, 14 authorized invention patents, and 34 utility model patents

·       12th Five-Year National Support Plan and the 13th Five-Year National Key Research and Development Plan

·       National and Zhongguancun high-tech enterprises, Beijing's first batch of G20 backup enterprises;

·       11 products with ISO-13485 quality system certification, 7 products with CFDA certificate, 4 with CE certificate, and exports to Europe and Japan.